{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:10:43Z","timestamp":1784268643569,"version":"3.55.0"},"reference-count":9,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2026.1873163","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:44:33Z","timestamp":1784267073000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Commentary: Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence"],"prefix":"10.3389","volume":"17","author":[{"given":"Hai-Hong","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Wenling TCM Hospital Affiliated to Zhejiang Chinese Medical University","place":["Wenling, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Li","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital","place":["Quzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Cheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Hao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital","place":["Quzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1808910","article-title":"Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence","volume":"17","author":"Li","year":"2026","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-025-00535-5","article-title":"Trends in adverse event reports of dipeptidyl peptidase-4 inhibitor-associated pemphigoid in Japan","volume":"13","author":"Takami","year":"2026","journal-title":"Drugs Real World Outcomes"},{"key":"B3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jamadermatol.2020.1587","article-title":"Association between medication use and bullous pemphigoid: a systematic review and meta-analysis","volume":"156","author":"Liu","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1745011","article-title":"Immune checkpoint inhibitor-induced bullous pemphigoid: a systematic review of clinical characteristics and outcomes based on case reports","volume":"17","author":"Chang","year":"2026","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbmt.2024.12.016","article-title":"Neck pain and text neck using Hill's criteria of causation: a scoping review","volume":"42","author":"Resende","year":"2025","journal-title":"J Bodyw Mov Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2026.106308","article-title":"Characteristics of online medication consultation from home-based patients on a tertiary hospital WeChat platform: a cross-sectional study","volume":"210","author":"Wang","year":"2026","journal-title":"Int J Med Inform"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22025","article-title":"Treatment strategies and pharmacist-led medication management for Helicobacter pylori infection","volume":"84","author":"Wang","year":"2023","journal-title":"Drug Dev Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000003667","article-title":"Bleeding and antiplatelet therapies: a combined pharmacovigilance analysis of the FDA adverse event reporting system and Japanese adverse drug event report databases, and the role of pharmacists","volume":"112","author":"Li","year":"2026","journal-title":"Int J Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1133662","article-title":"Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature","volume":"10","author":"Li","year":"2023","journal-title":"Front Cardiovasc Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1873163\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:44:34Z","timestamp":1784267074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1873163\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":9,"alternative-id":["10.3389\/fimmu.2026.1873163"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1873163","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1873163"}}